Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) Financials

$1.79

$0.07 (-3.76%)
Last update: 04:00 PM EST
Day's range
$1.77
Day's range
$1.95

ZYBT Income statement / Annual

Last year (2024), Zhengye Biotechnology Holding Limited's total revenue was $186.36 M, a decrease of 11.95% from the previous year. In 2024, Zhengye Biotechnology Holding Limited's net income was $11.31 M. See Zhengye Biotechnology Holding Limited,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $186.36 M $211.65 M $260.27 M $214.07 M
Cost of Revenue $95.06 M $81.80 M $106.75 M $88.67 M
Gross Profit $91.30 M $129.86 M $153.52 M $125.39 M
Gross Profit Ratio 0.49 0.61 0.59 0.59
Research and Development Expenses $12.79 M $11.90 M $13.42 M $11.37 M
General & Administrative Expenses $22.58 M $25.89 M $28.99 M $22.29 M
Selling & Marketing Expenses $41.27 M $40.74 M $34.57 M $35.90 M
Selling, General & Administrative Expenses $63.84 M $66.63 M $63.56 M $58.19 M
Other Expenses -$1.78 M $6.33 M $10.70 M $3.45 M
Operating Expenses $74.86 M $84.87 M $87.69 M $73.01 M
Cost And Expenses $169.92 M $166.67 M $194.44 M $161.68 M
Interest Income $231.00 K $312.00 K $114.00 K $112.00 K
Interest Expense $4.04 M $4.42 M $2.84 M $1.05 M
Depreciation & Amortization $24.16 M $23.91 M $18.80 M $16.01 M
EBITDA $42.60 M $72.10 M $85.55 M $70.12 M
EBITDA Ratio 0.23 0.34 0.33 0.33
Operating Income Ratio 0.09 0.21 0.25 0.24
Total Other Income/Expenses Net -$2.05 M -$1.22 M -$1.92 M $683.00 K
Income Before Tax $14.39 M $43.76 M $63.91 M $53.07 M
Income Before Tax Ratio 0.08 0.21 0.25 0.25
Income Tax Expense $924.00 K $6.25 M $8.17 M $6.60 M
Net Income $11.31 M $31.46 M $46.74 M $38.96 M
Net Income Ratio 0.06 0.15 0.18 0.18
EPS 0 0 0 0
EPS Diluted 0 0 0 0
Weighted Average Shares Out $0.00 $0.00 $0.00 $0.00
Weighted Average Shares Out Diluted $0.00 $0.00 $0.00 $0.00
Link